INER I-123

INER I-123 is a radiopharmaceutical agent labeled with the radioactive isotope iodine-123. It is used as a diagnostic imaging agent in nuclear medicine. The compound consists of a phenoxymethylmorpholine structure with an iodine-123 label, which emits gamma radiation suitable for detection by single-photon emission computed tomography (SPECT). Its primary use is for functional imaging of specific tissues or organs; however, detailed clinical indications and mechanism of action are not fully described in the available sources. The drug appears to be developed or associated with the Institute of Nuclear Energy Research (INER), Taiwan[3].

Other names

2(S)-((S)-(2-(123I)iodophenoxy)(phenyl)methyl)morpholine